ticlopidine has been researched along with Insulin Resistance in 6 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
Insulin Resistance: Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The aim of this study was to investigate the pharmacodynamic response to clopidogrel in patients with IGT and insulin resistance (IR)." | 9.20 | Impact of impaired glucose tolerance on clopidogrel response in patients with coronary artery disease. ( Angiolillo, DJ; Fujita, K; Ikeda, T; Ikuta, S; Iwanaga, Y; Kobuke, K; Miyazaki, S; Suga, T; Ueno, M; Yamaji, K; Yamamoto, H, 2015) |
| "The relation between high on-treatment platelet reactivity (HPR), and the level of glucose intolerance and insulin resistance (IR) was studied in clopidogrel-treated patients with minor ischemic stroke or TIA." | 7.80 | Glucose intolerance and insulin resistance as predictors of low platelet response to clopidogrel in patients with minor ischemic stroke or TIA. ( Jörneskog, G; Laska, AC; Lundström, A; Von Arbin, M; Wallén, H, 2014) |
| " The aim of this study was to investigate the pharmacodynamic response to clopidogrel in patients with IGT and insulin resistance (IR)." | 5.20 | Impact of impaired glucose tolerance on clopidogrel response in patients with coronary artery disease. ( Angiolillo, DJ; Fujita, K; Ikeda, T; Ikuta, S; Iwanaga, Y; Kobuke, K; Miyazaki, S; Suga, T; Ueno, M; Yamaji, K; Yamamoto, H, 2015) |
| "The relation between high on-treatment platelet reactivity (HPR), and the level of glucose intolerance and insulin resistance (IR) was studied in clopidogrel-treated patients with minor ischemic stroke or TIA." | 3.80 | Glucose intolerance and insulin resistance as predictors of low platelet response to clopidogrel in patients with minor ischemic stroke or TIA. ( Jörneskog, G; Laska, AC; Lundström, A; Von Arbin, M; Wallén, H, 2014) |
| " Therefore, several new antiplatelet treatment strategies have been developed in order to optimize platelet inhibition: a) modification of dosing of commonly used agents; b) use of new agents; and c) addition of a third antiplatelet drug (triple therapy)." | 2.48 | Challenges and perspectives of antiplatelet therapy in patients with diabetes mellitus and coronary artery disease. ( Angiolillo, DJ; Ferreiro, JL, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Zhao, X | 1 |
| Wang, J | 1 |
| Li, Q | 1 |
| Ye, Y | 1 |
| Zeng, Y | 1 |
| Lundström, A | 1 |
| Laska, AC | 1 |
| Von Arbin, M | 1 |
| Jörneskog, G | 1 |
| Wallén, H | 1 |
| Ueno, M | 1 |
| Fujita, K | 1 |
| Yamamoto, H | 1 |
| Ikeda, T | 1 |
| Suga, T | 1 |
| Yamaji, K | 1 |
| Ikuta, S | 1 |
| Kobuke, K | 1 |
| Iwanaga, Y | 1 |
| Angiolillo, DJ | 2 |
| Miyazaki, S | 1 |
| Kremneva, LV | 1 |
| Shalaev, SV | 1 |
| Ferreiro, JL | 1 |
| Mukherjee, D | 1 |
3 reviews available for ticlopidine and Insulin Resistance
| Article | Year |
|---|---|
[Acute coronary syndrome in patients with carbohydrate metabolic disturbances (a review)].
Topics: Acute Coronary Syndrome; Blood Glucose; Cardiovascular Diseases; Clinical Trials as Topic; Clopidogr | 2009 |
Challenges and perspectives of antiplatelet therapy in patients with diabetes mellitus and coronary artery disease.
Topics: Aspirin; Blood Glucose; Blood Platelets; Clopidogrel; Coronary Artery Disease; Diabetes Mellitus, Ty | 2012 |
Percutaneous coronary intervention versus coronary artery bypass grafting in diabetic patients.
Topics: Angioplasty, Balloon, Coronary; Clopidogrel; Coronary Artery Bypass; Diabetic Angiopathies; Humans; | 2005 |
1 trial available for ticlopidine and Insulin Resistance
| Article | Year |
|---|---|
Impact of impaired glucose tolerance on clopidogrel response in patients with coronary artery disease.
Topics: Aged; Clopidogrel; Coronary Artery Disease; Female; Glucose Tolerance Test; Humans; Insulin Resistan | 2015 |
2 other studies available for ticlopidine and Insulin Resistance
| Article | Year |
|---|---|
Impact of Pancreatic β-Cell Function on Clopidogrel Responsiveness and Outcomes in Chinese Nondiabetic Patients Undergoing Elective Percutaneous Coronary Intervention.
Topics: Clopidogrel; Diabetes Mellitus, Type 2; East Asian People; Humans; Insulin Resistance; Percutaneous | 2023 |
Glucose intolerance and insulin resistance as predictors of low platelet response to clopidogrel in patients with minor ischemic stroke or TIA.
Topics: Aged; Blood Glucose; Blood Platelets; Clopidogrel; Female; Glucose Intolerance; Humans; Insulin Resi | 2014 |